Molecular docking results indicated that quercetin, luteolin, and tanshinone IIA exhibited stable binding affinities with both PGK1 and LDHA, suggesting these components might be quite significant in treating DCM by modulating macrophage polarization. This evidence concerns the gene PGK1 and familial dilated cardiomyopathy.